Bristol-Myers Squibb Company BMY
NYSE · United States · Health Technology
$61.42-0.98 (-1.57%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-30 | 2.04 | 1.60 | +27.7% | $12.97B | +10.5% | +3.5%$63.10→$65.31 |
| Q1 2026 | 2026-04-30 | 1.58 | 1.42 | +11.3% | — | — | +1.1%$57.59→$58.22 |
| Q4 2025 | 2026-02-05 | 1.26 | 1.20 | +5.0% | — | — | +7.6%$57.62→$61.99 |
| Q3 2025 | 2025-10-30 | 1.63 | 1.52 | +7.2% | — | — | +8.1%$42.60→$46.07 |
| Q2 2025 | 2025-07-31 | 1.46 | 1.10 | +32.7% | — | — | — |
| Q1 2025 | 2025-04-24 | 1.80 | 1.50 | +20.0% | — | — | — |
| Q4 2024 | 2025-02-06 | 1.67 | 1.47 | +13.6% | — | — | — |
| Q3 2024 | 2024-10-31 | 1.80 | 1.50 | +20.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.